© 2020 MJH Life Sciences and OncLive. All rights reserved.
May 15, 2020
Naval G. Daver, MD, discusses anticipated breakthroughs in acute myeloid leukemia (AML).
March 06, 2020
Naval G. Daver, MD, discusses the results of a phase Ib/II study that evaluated the combination of azacitidine and nivolumab (Opdivo) in patients with relapsed/refractory acute myeloid leukemia.
February 26, 2020
Naval G. Daver, MD, discusses the rationale of azacitidine and nivolumab in acute myeloid leukemia.